The Paradox of Equipoise: The Principle that Drives and Limits Therapeutic Discoveries in Clinical Research
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Progress in clinical medicine relies on the willingness of patients to take part in experimental clinical trials, particularly randomized controlled trials (RCTs). Before agreeing to enroll in clinical trials, patients require guarantees that they will not knowingly be harmed and will have the best possible chances of receiving the most favorable treatments. This guarantee is provided by the acknowledgment of uncertainty (equipoise), which removes ethical dilemmas and makes it easier for patients to enroll in clinical trials. METHODS: Since the design of clinical trials is mostly affected by clinical equipoise, the "clinical equipoise hypothesis" has been postulated. If the uncertainty requirement holds, this means that investigators cannot predict what they are going to discover in any individual trial that they undertake. In some instances, new treatments will be superior to standard treatments, while in others, standard treatments will be superior to experimental treatments, and in still others, no difference will be detected between new and standard treatments. It is hypothesized that there must be a relationship between the overall pattern of treatment successes and the uncertainties that RCTs are designed to address. RESULTS: An analysis of published trials shows that the results cannot be predicted at the level of individual trials. However, the results also indicate that the overall pattern of discovery of treatment success across a series of trials is predictable and is consistent with clinical equipoise hypothesis. The analysis shows that we can discover no more than 25% to 50% of successful treatments when they are tested in RCTs. The analysis also indicates that this discovery rate is optimal in helping to preserve the clinical trial system; a high discovery rate (eg, a 90% to 100% probability of success) is neither feasible nor desirable since under these circumstances, neither the patient nor the researcher has an interest in randomization. This in turn would halt the RCT system as we know it. CONCLUSIONS: The "principle or law of clinical discovery" described herein predicts the efficiency of the current system of RCTs at generating discoveries of new treatments. The principle is derived from the requirement for uncertainty or equipoise as a precondition for RCTs, the precept that paradoxically drives discoveries of new treatments while limiting the proportion and rate of new therapeutic discoveries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Theory of Justice: Revised Edition
Rawls, J. (1999) · doi:10.4159/9780674042582 · Cited by 9,455
Newman (2005) · doi:10.1080/00107510500052444 · Cited by 5,749
Equipoise and the Ethics of Clinical Research
Freedman, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707163170304 · Cited by 2,339
Robertson, H. P. (1929) · Physical Review · doi:10.1103/physrev.34.163 · Cited by 1,877
Mills, N., Donovan, J. L., Smith, M., Jacoby, A., Neal, D. E., & Hamdy, F. C. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00020-5 · Cited by 142
Well informed uncertainties about the effects of treatments
Chalmers, I. (2004) · BMJ · doi:10.1136/bmj.328.7438.475 · Cited by 117
Cited by
Empirical Evaluation of Very Large Treatment Effects of Medical Interventions
Pereira, T. V., Horwitz, R. I., & Ioannidis, J. P. A. (2012) · JAMA · doi:10.1001/jama.2012.13444 · Cited by 257
Flacco, M. E., Manzoli, L., Boccia, S., Capasso, L., Aleksovska, K., Rosso, A., Scaioli, G., De Vito, C., Siliquini, R., Villari, P., et al. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.12.016 · Cited by 177
Elliott, D., Husbands, S., Hamdy, F. C., Holmberg, L., & Donovan, J. L. (2017) · European Urology · doi:10.1016/j.eururo.2017.04.036 · Cited by 161
“Lack of equipoise between RCT treatment options ‘‘Community equipoise’’ refers to the principle that there is uncertainty or disagreement in the clinical community about which treatment is best [57], whilst ‘‘individual equipoise’’ exists when an individual is uncertain about treatment superiority [58].”
BackgroundRooshenas, L., Elliott, D., Wade, J., Jepson, M., Paramasivan, S., Strong, S., Wilson, C., Beard, D., Blazeby, J. M., Birtle, A., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002147 · Cited by 140
Estellat, C., Tubach, F., Seror, R., Alfaiate, T., Hajage, D., De Rycke, Y., & Ravaud, P. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.08.016 · Cited by 4
Metadata
- Authors
- Djulbegovic, B.
- Venue
- Cancer Control
- Publisher
- SAGE Publications
- Published
- 2009-10
- Volume
- 16
- Issue
- 4
- Pages
- 342-347
- ISSN
- 1073-2748 (ISSN-L)
- OpenAlex
- W2162590828
- Cited by
- 65
- References
- 6
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Paradox of Equipoise: The Principle that Drives and Limits Therapeutic Discoveries in Clinical Research. https://app.cochat.ai/papers/10.1177/107327480901600409
- The paper
- Djulbegovic, B. (2009). The Paradox of Equipoise: The Principle that Drives and Limits Therapeutic Discoveries in Clinical Research. Cancer Control. https://doi.org/10.1177/107327480901600409
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.